Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huangqi Gegen Decoction for Endothelial Function in T2DM with ASCVD Risk
NCT07775664Active, not recruiting
- Sponsor
- Central Hospital of Shanghai Putuo District
- Start
- Aug 2026
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and endothelial dysfunction (2 arms), sponsored by Central Hospital of Shanghai Putuo District. Primary endpoint: Flow-Mediated Dilation at 12 weeks. Started Aug 2026; status: active, not recruiting.
02
Conditions
type 2 diabetes mellitus (T2DM)endothelial dysfunction
Beyond the preview
Go deeper on NCT07775664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07775664.